The Latin America, Middle East and Africa In Vitro Toxicity Testing Market would witness market growth of 13.9% CAGR during the forecast period (2022-2028).
In-vitro toxicology tests for evaluating drug product safety, along with the evaluation of the possible effect of medicines on cells and tissues, are expected to boost revenue growth in the market. Companies have diversified their portfolios to meet competition in the market for in-vitro toxicology testing, as the demand for such tests has grown.
Even though the in vitro toxicity business is relatively new, it has a lot of potential for further development. This industry would be dominated by technological advancements and the introduction of new products. The absence of pharmaceutical powerhouses in this sector provides a better opportunity for newcomers to position themselves in the market. As a result, a corporation planning to spend can enter this expanding market and be successful, as the market has a lot of room for new competitors.
In Brazil the Guidance for Safety Assessment of Cosmetic Products has been updated to provide criteria for evaluating the safety of cosmetics sold in Brazil as well as information on testing methods. The Guideline does not mandate any specific test for skin sensitivity assessment, however, it does recommend the LLNA. The GPMT, the Buehler test, and clinical studies like the human repeat shock physical exam are all covered.
In Brazil, a risk evaluation is required before cosmetic compounds can be classified as skin sensitizers or nonsensitizers. Alternative approaches are accepted, subject to the limits of each technique and their regulatory implications. In silico methodologies, such as structure-activity relationships, are, for example, accepted when utilized as a part of integrated testing and assessment procedures.
The UAE government wants to enhance healthcare funding so that more data monitoring tools can be used for proactive COVID contact tracking and virtual healthcare service providers can be licensed. The government also intends to strengthen national capacities to combat future pandemics, including initiatives to create vaccines and medications, as well as digital immunization IDs and a new supply chain strategy. The Ministry of Health wants to grow the sector by putting more emphasis on health information technology, such as telehealth and digital medicine.
The Brazil market dominated the LAMEA In Vitro Toxicity Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $763.1 Million by 2028. The Argentina market is poised to grow at a CAGR of 14.5% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.6% during (2022 - 2028).
Based on Type, the market is segmented into Absorption, Toxic Substances, and Dose. Based on Technology, the market is segmented into Cell Culture Technologies, High Throughput Technologies, and Toxicogenomics. Based on End User, the market is segmented into Cosmetics & Households Products, Pharmaceuticals Industry, Food Industry, Chemicals, and Industry. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global In Vitro Toxicity Testing Market is Predict to reach $37.5 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., General Electric (GE) Co., AstraZeneca PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Acacia Pharma Group Plc, GlaxoSmithKline PLC, Helsinn Healthcare SA., and Heron Therapeutics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Absorption
- Toxic Substances
- Dose
By Technology
- Cell Culture Technologies
- High Throughput Technologies
- Toxicogenomics
By End User
- Cosmetics & Households Products
- Pharmaceuticals Industry
- Food Industry
- Chemicals Industry
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- General Electric (GE) Co.
- AstraZeneca PLC
- Catalent, Inc.
- Laboratory Corporation of America Holdings
- Acacia Pharma Group Plc
- GlaxoSmithKline PLC
- Helsinn Healthcare SA.
- Heron Therapeutics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA In Vitro Toxicity Testing Market, by Type
1.4.2 LAMEA In Vitro Toxicity Testing Market, by Technology
1.4.3 LAMEA In Vitro Toxicity Testing Market, by End User
1.4.4 LAMEA In Vitro Toxicity Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA In Vitro Toxicity Testing Market by Type
3.1 LAMEA Absorption Market by Country
3.2 LAMEA Toxic Substances Market by Country
3.3 LAMEA Dose Market by Country
Chapter 4. LAMEA In Vitro Toxicity Testing Market by Technology
4.1 LAMEA Cell Culture Technologies Market by Country
4.2 LAMEA High Throughput Technologies Market by Country
4.3 LAMEA Toxicogenomics Market by Country
Chapter 5. LAMEA In Vitro Toxicity Testing Market by End User
5.1 LAMEA Cosmetics & Households Products Market by Country
5.2 LAMEA Pharmaceuticals Industry Market by Country
5.3 LAMEA Food Industry Market by Country
5.4 LAMEA Chemicals Industry Market by Country
Chapter 6. LAMEA In Vitro Toxicity Testing Market by Country
6.1 Brazil In Vitro Toxicity Testing Market
6.1.1 Brazil In Vitro Toxicity Testing Market by Type
6.1.2 Brazil In Vitro Toxicity Testing Market by Technology
6.1.3 Brazil In Vitro Toxicity Testing Market by End User
6.2 Argentina In Vitro Toxicity Testing Market
6.2.1 Argentina In Vitro Toxicity Testing Market by Type
6.2.2 Argentina In Vitro Toxicity Testing Market by Technology
6.2.3 Argentina In Vitro Toxicity Testing Market by End User
6.3 UAE In Vitro Toxicity Testing Market
6.3.1 UAE In Vitro Toxicity Testing Market by Type
6.3.2 UAE In Vitro Toxicity Testing Market by Technology
6.3.3 UAE In Vitro Toxicity Testing Market by End User
6.4 Saudi Arabia In Vitro Toxicity Testing Market
6.4.1 Saudi Arabia In Vitro Toxicity Testing Market by Type
6.4.2 Saudi Arabia In Vitro Toxicity Testing Market by Technology
6.4.3 Saudi Arabia In Vitro Toxicity Testing Market by End User
6.5 South Africa In Vitro Toxicity Testing Market
6.5.1 South Africa In Vitro Toxicity Testing Market by Type
6.5.2 South Africa In Vitro Toxicity Testing Market by Technology
6.5.3 South Africa In Vitro Toxicity Testing Market by End User
6.6 Nigeria In Vitro Toxicity Testing Market
6.6.1 Nigeria In Vitro Toxicity Testing Market by Type
6.6.2 Nigeria In Vitro Toxicity Testing Market by Technology
6.6.3 Nigeria In Vitro Toxicity Testing Market by End User
6.7 Rest of LAMEA In Vitro Toxicity Testing Market
6.7.1 Rest of LAMEA In Vitro Toxicity Testing Market by Type
6.7.2 Rest of LAMEA In Vitro Toxicity Testing Market by Technology
6.7.3 Rest of LAMEA In Vitro Toxicity Testing Market by End User
Chapter 7. Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 General Electric (GE) Co.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 AstraZeneca PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Catalent, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Laboratory Corporation of America Holdings (Covance, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Acquisition and Mergers:
7.6 Acacia Pharma Group Plc
7.6.1 Company Overview
7.7 GlaxoSmithKline PLC (TESARO, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Helsinn Healthcare SA.
7.8.1 Company Overview
7.9 Heron Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
TABLE 1 LAMEA In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 2 LAMEA In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 3 LAMEA In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 4 LAMEA In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Absorption Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Absorption Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Toxic Substances Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Toxic Substances Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Dose Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Dose Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 12 LAMEA In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 13 LAMEA Cell Culture Technologies Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Cell Culture Technologies Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA High Throughput Technologies Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA High Throughput Technologies Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Toxicogenomics Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Toxicogenomics Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 LAMEA In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 LAMEA Cosmetics & Households Products Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Cosmetics & Households Products Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Pharmaceuticals Industry Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Pharmaceuticals Industry Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Food Industry Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Food Industry Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Chemicals Industry Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Chemicals Industry Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA In Vitro Toxicity Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA In Vitro Toxicity Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 Brazil In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 32 Brazil In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 33 Brazil In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 34 Brazil In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 35 Brazil In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 36 Brazil In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 37 Brazil In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 38 Brazil In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 39 Argentina In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 40 Argentina In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 41 Argentina In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 42 Argentina In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 43 Argentina In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 44 Argentina In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 45 Argentina In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 46 Argentina In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 47 UAE In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 48 UAE In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 49 UAE In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 50 UAE In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 51 UAE In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 52 UAE In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 53 UAE In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 UAE In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 63 South Africa In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 64 South Africa In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 65 South Africa In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 66 South Africa In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 67 South Africa In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 68 South Africa In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 69 South Africa In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 70 South Africa In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 71 Nigeria In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 72 Nigeria In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 73 Nigeria In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 74 Nigeria In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 75 Nigeria In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 76 Nigeria In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 77 Nigeria In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 78 Nigeria In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 KEY INFORMATION – GENERAL ELECTRIC (GE) CO.
TABLE 89 KEY INFORMATION – ASTRAZENECA PLC
TABLE 90 Key information – CATALENT, INC.
TABLE 91 Key Information – Laboratory Corporation of America holdings
TABLE 92 Key Information – Acacia Pharma Group Plc
TABLE 93 Key Information – GlaxoSmithKline PLC
TABLE 94 Key Information – Helsinn Healthcare SA.
TABLE 95 Key Information – Heron Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: thermo fisher scientific, inc.
FIG 3 Swot analysis: General electric (GE) Co.